FMP

FMP

Enter

VIRI - Virios Therapeutics,...

Financial Summary of Virios Therapeutics, Inc.(VIRI), Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antivira

photo-url-https://financialmodelingprep.com/image-stock/VIRI.png

Virios Therapeutics, Inc.

VIRI

NASDAQ

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.

0.207 USD

-0.0129 (-6.23%)

About

ceo

Mr. Gregory Duncan

sector

Healthcare

industry

Biotechnology

website

https://www.virios.com

exchange

NASDAQ

Description

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and i...

CIK

0001818844

ISIN

US92829J1043

CUSIP

92829J104

Address

44 Milton Avenue

Phone

866 620 8655

Country

US

Employee

4

IPO Date

Dec 17, 2020

Summary

CIK

0001818844

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

92829J104

ISIN

US92829J1043

Country

US

Price

0.21

Beta

1.87

Volume Avg.

578.35k

Market Cap

5.75M

Shares

-

52-Week

0.156-2.42

DCF

0.18

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.77

P/B

-

Website

https://www.virios.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest VIRI News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep